Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 11 | ECE2006 | Next issue

8th European Congress of Endocrinology incorporating the British Endocrine Societies

Poster Presentations

Neuroendocrinology and behaviour

Previous section
Growth and development
Table of contents
Next section
Reproduction

ea0011p575 | Neuroendocrinology and behaviour

Association between the LRP5 gene and serum post-menopausal follicle stimulating hormone levels

ea0011p576 | Neuroendocrinology and behaviour

Structural analysis of somatotrophs and lactotrophs in annexin 1 null mice

ea0011p577 | Neuroendocrinology and behaviour

Dietary supplements for stress and obesity co-morbidities reduction

ea0011p578 | Neuroendocrinology and behaviour

The impact of hypothalamic-pituitary (h-p) irradiation on the TSH Bio/Immuno (B/I) ratio in the fed and fasting states

ea0011p579 | Neuroendocrinology and behaviour

Comparison of the catecholaminergic response to 2 different stressors in healthy men

ea0011p580 | Neuroendocrinology and behaviour

Effect of gastric bypass and gastric banding on neurotensin levels in morbidly obese patients

ea0011p581 | Neuroendocrinology and behaviour

Mental and neuropsychological disorders of children with congenital hypothyroidism

ea0011p582 | Neuroendocrinology and behaviour

Hypopituitary patients have a high occurrence of metabolic syndrome markers and an increased prevalence of cardiovascular risk factors

ea0011p583 | Neuroendocrinology and behaviour

Spontaneous GH secretion in the fed and fasting states in cranially irradiated adult cancer survivors with normal peak GH responses to two provocative tests: does GH neurosecretory dysfunction exist?

ea0011p584 | Neuroendocrinology and behaviour

The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis

ea0011p585 | Neuroendocrinology and behaviour

GH secretion in amyotrophic lateral sclerosis

ea0011p586 | Neuroendocrinology and behaviour

Clinical significance of macroprolactin

ea0011p587 | Neuroendocrinology and behaviour

ADH and thirst function in defence with hypernatremia formation

ea0011p588 | Neuroendocrinology and behaviour

The effect of garlic odor on appetite center

ea0011p589 | Neuroendocrinology and behaviour

Taste protective mechanism in relation with salt

ea0011p590 | Neuroendocrinology and behaviour

The effect of salt on night sleep

ea0011p591 | Neuroendocrinology and behaviour

Evaluation of cognitive functions by using p300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and gh excess

ea0011p592 | Neuroendocrinology and behaviour

Appetite regulating hormones in constitutionally lean and anorexia nervosa subjects

ea0011p593 | Neuroendocrinology and behaviour

Differentiation of TSH-oma from thyroid hormone resistance syndrome using thyroid color Doppler sonography

ea0011p594 | Neuroendocrinology and behaviour

Maternal consumption of a high-meat, low carbohydrate diet in late pregnancy and stress responsiveness in the offspring

ea0011p595 | Neuroendocrinology and behaviour

Patients with pituitary disease who have had radiotherapy have reduced cerebral vasomotor reactivity

ea0011p596 | Neuroendocrinology and behaviour

An open label, controlled study to assess the ability of patients with acromegaly, or their partners, to administer Somatuline Autogel®

ea0011p597 | Neuroendocrinology and behaviour

The effect of dopamine on neuroendocrine disorders in women with PCOS under chronic stress conditions

ea0011p598 | Neuroendocrinology and behaviour

Measurement of basal cortisol in serum and saliva for the diagnosis of secondary adrenal insufficiency

ea0011p599 | Neuroendocrinology and behaviour

Sensitivity and specificity of different provocative tests for the diagnosis of secondary hypoadrenalism in patients with hypothalamo-pituitary disorders

ea0011p600 | Neuroendocrinology and behaviour

Pulmonary function in Cushing’s disease

ea0011p601 | Neuroendocrinology and behaviour

Adenosine stimulates connexin 43 expression and increases intercellular communication in the folliculostellate cells of the anterior pituitary gland

ea0011p602 | Neuroendocrinology and behaviour

Complement C5a inhibits the secretion of macrophage migration inhibitory factor (MIF) in anterior pituitary cell lines

ea0011p603 | Neuroendocrinology and behaviour

Unrecognized chronic hypopituitarism in patients who survived hemorrhagic fever with renal syndrome

ea0011p604 | Neuroendocrinology and behaviour

Ghrelin test for the assessment of growth hormone (GH) status in successfully treated patients with acromegaly

ea0011p605 | Neuroendocrinology and behaviour

The thickening of the pituitary stem In connection with 06 cases

ea0011p606 | Neuroendocrinology and behaviour

Effectiveness of the association of Bromocriptine and Cabergoline in the treatment of 05 invasif and giants prolactin macroadenoma

ea0011p607 | Neuroendocrinology and behaviour

Hypothalamic-pituitary dysfunction following irradiation of non-pituitary brain tumours in adults

ea0011p608 | Neuroendocrinology and behaviour

Bone mass and metabolism in active acromegaly – no impact of gonadal status. a study of 73 patients

ea0011p609 | Neuroendocrinology and behaviour

Effect of pegvisomant on glucose metabolism

ea0011p610 | Neuroendocrinology and behaviour

Psychological and gastrointestinal problems in anorexia nervosa patients

ea0011p611 | Neuroendocrinology and behaviour

Octreotide shrinks the cellular rather than the vascular compartment in acromegalic tumours in vivo

ea0011p612 | Neuroendocrinology and behaviour

Positive correlation between AcroQol and SF-36 and negative with BDI in sample of 60 acromegalics

ea0011p613 | Neuroendocrinology and behaviour

Quality of life (QoL) and psychiatric sequelae following aneurysmal subarachnoid hemorrhage (SAH): Does neuroendocrine dysfunction play a role?

ea0011p614 | Neuroendocrinology and behaviour

Pituitary function in patients with detectable serum pituitary autoantibodies

ea0011p615 | Neuroendocrinology and behaviour

Prevalence of pituitary autoantibodies in thyroid disorders

ea0011p616 | Neuroendocrinology and behaviour

Rate of change in size of macroprolactinomas with dopamine agonist therapy – is there any relationship to fall in prolactin concentrations?

ea0011p617 | Neuroendocrinology and behaviour

The levels of ghrelin and leptin and body fat mass in patients treated for thyroid dysfunction

ea0011p618 | Neuroendocrinology and behaviour

Night sleep affected by salt

ea0011p619 | Neuroendocrinology and behaviour

ADH and Thirst Function in Defence with Hypernatremia Formation

ea0011p620 | Neuroendocrinology and behaviour

Taste protective mechanism in relation with salt

ea0011p621 | Neuroendocrinology and behaviour

Cushing’s syndrome as a model to investigate the effects on cognition of high circulating levels of glucocorticoid

ea0011p622 | Neuroendocrinology and behaviour

The influence of growth hormone replacement (GHR) in adults with GH deficiency (GHD) on body composition, basal metabolic rate, physical activity and ingestive behaviour

ea0011p623 | Neuroendocrinology and behaviour

Influence of affective changes on cortisol response to ACTH

ea0011p624 | Neuroendocrinology and behaviour

Interest of a single treatment by somatostatin analogues in a macroadenoma secreting TSH and GH

ea0011p625 | Neuroendocrinology and behaviour

Dehydroepiandrosterone (DHEA) improves psychological well-being in male and female hypopituitary patients in addition to growth hormone replacement (GHR)

ea0011p626 | Neuroendocrinology and behaviour

The influence of a GH receptor antagonist (GHRA) on the relationship between GH and IGF-I in adults with severe growth hormone deficiency (AGHD)

ea0011p627 | Neuroendocrinology and behaviour

Can adults with severe growth hormone deficiency (AsGHD) and a low IGF-I be distinguished from those with a normal IGF-I?

ea0011p628 | Neuroendocrinology and behaviour

Sleep disorders in acromegaly: preliminary data demonstrating a high prevalence of restless leg syndrome (RLS)

ea0011p629 | Neuroendocrinology and behaviour

Risk factors for the development of atherosclerosis in patients with acromegaly

ea0011p630 | Neuroendocrinology and behaviour

Microalbuminuria as well as insulin sensitivity are improved under octreotide-lar treatment in acromegalic patients

ea0011p631 | Neuroendocrinology and behaviour

Pro-opiomelanocortin and ACTH, precursors of alphaMSH, are secreted from human melanocytes and keratinocytes and can stimulate melanogenesis

ea0011p632 | Neuroendocrinology and behaviour

Processing and sorting of pro-opiomelanocortin is an important checkpoint in regulating release of ACTH from secretory vesicles in pituitary cells

ea0011p633 | Neuroendocrinology and behaviour

Hormone therapy effects on sleep and dreams in menopausal women

ea0011p634 | Neuroendocrinology and behaviour

Glucose-suppressed GH levels compared with IGF-I levels in patients with acromegaly

ea0011p635 | Neuroendocrinology and behaviour

Loss of rise in awakening cortisol response in prepubertal survivors of leukaemia post bone marrow transplantation and chemotherapy treatment

ea0011p636 | Neuroendocrinology and behaviour

The incidence of spontaneous cerebro-spinal fluid rhinorrhea in a large series of patients with macroprolactinoma

ea0011p637 | Neuroendocrinology and behaviour

Gonadotropin levels in the cerebrospinal fluid (CSF) as a marker of the gonadotropin secretion from non-functioning pituitary adenomas

ea0011p638 | Neuroendocrinology and behaviour

Prolonged post-operative follow-up is necessary for unirradiated non-functioning pituitary adenomata

ea0011p639 | Neuroendocrinology and behaviour

Anterior pituitary hormone dysfunction after traumatic brain injury: less common than previously thought?

ea0011p640 | Neuroendocrinology and behaviour

Effects of long-term GH treatment in Prader-Willi adults

ea0011p641 | Neuroendocrinology and behaviour

Endocrine abnormalities are common in transsexual individuals

ea0011p642 | Neuroendocrinology and behaviour

Glucagon-induced suppression of ghrelin secretion is exerted at hypothalamus-pituitary level and is not mediated by an increase in catecholamine secretion

ea0011p643 | Neuroendocrinology and behaviour

Complications of hormonal therapy in male to female transsexuals is uncommon

ea0011p644 | Neuroendocrinology and behaviour

Effects of targeted ablation of GHRH neurons in mice on anterior pituitary somatotrophs and lactotrophs

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more